Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract

A. H. Chow, Shih-Ming Huang, S. H. Chan, L. R. Mo, M. H. Hwang, W. C. Su

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

There were few, but conflicting, reports dealing with the clinical significance of c-erbB-2 in biliary tract cancer. We evaluated the expression of c-erbB-2 in normal epithelium of bile ducts (n = 46), gallbladder cancer (n = 11), carcinoma of the ampulla of Vater (n = 18), and intrahepatic cholangiocarcinoma (CC) (n = 18). c-erbB-2 protein is present in 63% (29/46) of surface epithelium in large and septal bile ducts, but not in peripheral small ducts. Overexpression of the gene product was found in 27.8% (5/18) of intrahepatic CC, 27.8% (5/18) of carcinoma of the ampulla of Vater, and 63.6% (7/11) of gallbladder cancer. But, there was no c-erbB-2 overexpression in the hyperplasia or atypical hyperplastic bile duct epithelium (p = 0.002). In terms of prognostic implication, expression of c-erbB-2 did not correlate to the histopathological grade (p = 0.60) and tumor stage (p = 0.63). The results indicate that c-erbB-2 protein may play some roles in physiology of normal bile ducts. Overexpression of the gene product occurs in one forth to about two thirds of carcinoma of biliary tract, and may be used as phenotypic marker for neoplastic transformation. However, the gene product may not be important in the aggressive behavior of tumor.

Original languageEnglish
Pages (from-to)1055-1059
Number of pages5
JournalAnticancer Research
Volume15
Issue number3
Publication statusPublished - 1995 Jan 1

Fingerprint

Biliary Tract
Bile Ducts
Epithelium
ErbB-2 Receptor
Ampulla of Vater
Gallbladder Neoplasms
Cholangiocarcinoma
Carcinoma
Biliary Tract Neoplasms
Genes
Hyperplasia
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Chow, A. H., Huang, S-M., Chan, S. H., Mo, L. R., Hwang, M. H., & Su, W. C. (1995). Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract. Anticancer Research, 15(3), 1055-1059.
Chow, A. H. ; Huang, Shih-Ming ; Chan, S. H. ; Mo, L. R. ; Hwang, M. H. ; Su, W. C. / Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract. In: Anticancer Research. 1995 ; Vol. 15, No. 3. pp. 1055-1059.
@article{bf013af655184158805a4cfb79572fd8,
title = "Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract",
abstract = "There were few, but conflicting, reports dealing with the clinical significance of c-erbB-2 in biliary tract cancer. We evaluated the expression of c-erbB-2 in normal epithelium of bile ducts (n = 46), gallbladder cancer (n = 11), carcinoma of the ampulla of Vater (n = 18), and intrahepatic cholangiocarcinoma (CC) (n = 18). c-erbB-2 protein is present in 63{\%} (29/46) of surface epithelium in large and septal bile ducts, but not in peripheral small ducts. Overexpression of the gene product was found in 27.8{\%} (5/18) of intrahepatic CC, 27.8{\%} (5/18) of carcinoma of the ampulla of Vater, and 63.6{\%} (7/11) of gallbladder cancer. But, there was no c-erbB-2 overexpression in the hyperplasia or atypical hyperplastic bile duct epithelium (p = 0.002). In terms of prognostic implication, expression of c-erbB-2 did not correlate to the histopathological grade (p = 0.60) and tumor stage (p = 0.63). The results indicate that c-erbB-2 protein may play some roles in physiology of normal bile ducts. Overexpression of the gene product occurs in one forth to about two thirds of carcinoma of biliary tract, and may be used as phenotypic marker for neoplastic transformation. However, the gene product may not be important in the aggressive behavior of tumor.",
author = "Chow, {A. H.} and Shih-Ming Huang and Chan, {S. H.} and Mo, {L. R.} and Hwang, {M. H.} and Su, {W. C.}",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "15",
pages = "1055--1059",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3",

}

Chow, AH, Huang, S-M, Chan, SH, Mo, LR, Hwang, MH & Su, WC 1995, 'Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract', Anticancer Research, vol. 15, no. 3, pp. 1055-1059.

Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract. / Chow, A. H.; Huang, Shih-Ming; Chan, S. H.; Mo, L. R.; Hwang, M. H.; Su, W. C.

In: Anticancer Research, Vol. 15, No. 3, 01.01.1995, p. 1055-1059.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract

AU - Chow, A. H.

AU - Huang, Shih-Ming

AU - Chan, S. H.

AU - Mo, L. R.

AU - Hwang, M. H.

AU - Su, W. C.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - There were few, but conflicting, reports dealing with the clinical significance of c-erbB-2 in biliary tract cancer. We evaluated the expression of c-erbB-2 in normal epithelium of bile ducts (n = 46), gallbladder cancer (n = 11), carcinoma of the ampulla of Vater (n = 18), and intrahepatic cholangiocarcinoma (CC) (n = 18). c-erbB-2 protein is present in 63% (29/46) of surface epithelium in large and septal bile ducts, but not in peripheral small ducts. Overexpression of the gene product was found in 27.8% (5/18) of intrahepatic CC, 27.8% (5/18) of carcinoma of the ampulla of Vater, and 63.6% (7/11) of gallbladder cancer. But, there was no c-erbB-2 overexpression in the hyperplasia or atypical hyperplastic bile duct epithelium (p = 0.002). In terms of prognostic implication, expression of c-erbB-2 did not correlate to the histopathological grade (p = 0.60) and tumor stage (p = 0.63). The results indicate that c-erbB-2 protein may play some roles in physiology of normal bile ducts. Overexpression of the gene product occurs in one forth to about two thirds of carcinoma of biliary tract, and may be used as phenotypic marker for neoplastic transformation. However, the gene product may not be important in the aggressive behavior of tumor.

AB - There were few, but conflicting, reports dealing with the clinical significance of c-erbB-2 in biliary tract cancer. We evaluated the expression of c-erbB-2 in normal epithelium of bile ducts (n = 46), gallbladder cancer (n = 11), carcinoma of the ampulla of Vater (n = 18), and intrahepatic cholangiocarcinoma (CC) (n = 18). c-erbB-2 protein is present in 63% (29/46) of surface epithelium in large and septal bile ducts, but not in peripheral small ducts. Overexpression of the gene product was found in 27.8% (5/18) of intrahepatic CC, 27.8% (5/18) of carcinoma of the ampulla of Vater, and 63.6% (7/11) of gallbladder cancer. But, there was no c-erbB-2 overexpression in the hyperplasia or atypical hyperplastic bile duct epithelium (p = 0.002). In terms of prognostic implication, expression of c-erbB-2 did not correlate to the histopathological grade (p = 0.60) and tumor stage (p = 0.63). The results indicate that c-erbB-2 protein may play some roles in physiology of normal bile ducts. Overexpression of the gene product occurs in one forth to about two thirds of carcinoma of biliary tract, and may be used as phenotypic marker for neoplastic transformation. However, the gene product may not be important in the aggressive behavior of tumor.

UR - http://www.scopus.com/inward/record.url?scp=0028869784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028869784&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 1055

EP - 1059

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3

ER -